Trademarkia Logo

Canada

C$
PSYBINA
SEARCHED

on 20 Dec 2024

Last Applicant/ Owned by

Numinus Bioscience

950 Old Victoria RdNanaimo

BRITISH COLUMBIA

CA

V9R6Z8

Serial Number

2130301 filed on 31st Aug 2021

Correspondent Address

NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L.

1, Place Ville MarieSuite 2500, Montreal

QUEBEC

CA

H3B1R1

PSYBINA

Trademark usage description

pharmaceutical preparations for the treatment of psychiatric diseases and disorders, neurological disorders, neuroinflammatory disorders, brain injury Read More

Classification Information


Class [001]
Chemicals and adhesives


Comment text

CIPO Classification Code

Classification kind code

Nice

Class [005]
Pharmaceutical preparations for the treatment of psychiatric diseases and disorders, neurological disorders, neuroinflammatory disorders, brain injury, and sleep disorders; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the relief of pain; pharmaceutical preparations and substances containing psychedelic extracts; substances for use in the formulation of pharmaceutical and therapeutic preparations, namely extracts of psychedelic mushrooms.


Classification kind code

11

Class [044]
Psychotherapy services; mental health services; providing mental health counselling and psychotherapy assisted by psychedelic medicines; treatment of psychiatric diseases and disorders, neurological disorders, neuroinflammatory disorders, brain injury, and sleep disorders.


Classification kind code

11

Mark Details


Serial Number

2130301

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 20th Dec 2024
Search Recorded
Submitted for opposition 20
on 20th Dec 2024
Examiner's First Report
Submitted for opposition 287
on 27th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 287
on 26th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 31st Aug 2021
Filed
Submitted for opposition 1
on 31st Aug 2021
Created
Submitted for opposition 31
on 31st Aug 2021
Formalized